Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
None USD 0.00(0%)
Last update at 2026-11-17T21:02:07.687151Z
Market Cap
0.01M

Momentum Score

…

ChromoCure, Inc. develops and provides proprietary cancer detection systems. The company offers Chromosomal Scanner Series 200, a cancer detection system to measure the genomic characteristic found in 100% of all cancers and never found in normal cells. It also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research. The company was formerly known as Cyberhand Technologies International, Inc. and changed its name to ChromoCure, Inc. in June 2009. ChromoCure, Inc. was incorporated in 2001 and is based in Reno, Nevada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
-
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
-7.82%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2009-12-31 2008-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly
Date 2009-12-31 2008-12-31 2005-12-31 2004-12-31
Income before tax -0.15M -0.06M -0.17M -0.41M
Minority interest 0.00M 0.00M 0.00M 0.00M
Net income -0.15M -0.06M -0.17M -0.41M
Selling general administrative 0.12M 0.05M 0.32M 0.18M
Gross profit 0.00M 0.00M 0.25M 0.05M
Ebit -0.13M -0.06M -0.17M -0.41M
Non operating income net other 0.00M 0.00M 0.00M 0.00M
Operating income -0.13M -0.06M -0.17M -0.41M
Other operating expenses 0.00M 0.00M 0.00M 0.00M
Interest expense 0.00M 0.00M 0.00M 0.00M
Extraordinary items 0.00M 0.00M 0.00M 0.00M
Non recurring 0.00M 0.00M 0.00M 0.00M
Other items 0.00M 0.00M 0.00M 0.00M
Income tax expense 0.00M 0.00M 0.00M 0.00M
Total revenue 0.00M 0.00M 0.28M 0.05M
Total operating expenses 0.13M 0.06M 0.45M 0.46M
Cost of revenue 0.00M 0.00M 0.03M 0.00M
Total other income expense net -0.02M 0.00M 0.00M 0.00M
Discontinued operations 0.00M 0.00M 0.00M 0.00M
Net income from continuing ops -0.15M -0.06M -0.17M -0.41M
Net income applicable to common shares -0.15M -0.06M -0.17M -0.41M
Preferred stock and other adjustments 0.00M 0.00M 0.00M 0.00M
Breakdown 2009-12-31 2008-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly
Date 2009-12-31 2008-12-31 2005-12-31 2004-12-31
Total assets 1.61M 0.34M 0.35M 0.10M
Intangible assets 1.35M 0.02M 0.00M 0.00M
Other current assets 0.00M 0.00M 0.00M 0.00M
Total liab 1.08M 1.00M 0.52M 0.36M
Total stockholder equity 0.46M -0.73M -0.17M -0.26M
Deferred long term liab 0.00M 0.00M 0.00M 0.00M
Other current liab 0.00M 0.00M 0.00M 0.00M
Common stock 0.27M 0.05M 0.59M 0.49M
Retained earnings -1.32M -1.18M -0.92M -0.75M
Other liab 0.00M 0.20M 0.00M 0.00M
Good will 0.00M 0.00M 0.00M 0.00M
Other assets 0.00M 0.00M 0.00M 0.00M
Cash 0.11M 0.00M 0.03M 0.04M
Total current liabilities 0.00M 0.00M 0.52M 0.36M
Short term debt 0.00M 0.00M 0.00M 0.00M
Short long term debt 0.00M 0.00M 0.00M 0.00M
Other stockholder equity 0.00M 0.00M 0.17M 0.00M
Property plant equipment 0.15M 0.00M 0.00M 0.00M
Total current assets 0.11M 0.32M 0.34M 0.09M
Long term investments 0.00M 0.00M 0.01M 0.01M
Net tangible assets -0.89M -0.75M -0.17M -0.26M
Short term investments 0.00M 0.00M 0.00M 0.00M
Net receivables - - 0.14M 0.05M
Long term debt 1.08M 0.80M 0.00M 0.00M
Inventory 0.00M 0.32M 0.18M 0.00M
Accounts payable 0.00M 0.00M 0.10M 0.10M
Total permanent equity 0.00M 0.00M 0.00M 0.00M
Noncontrolling interest in consolidated entity 0.00M 0.00M 0.00M 0.00M
Temporary equity redeemable noncontrolling interests 0.00M 0.00M 0.00M 0.00M
Accumulated other comprehensive income 0.00M 0.00M 0.00M 0.00M
Additional paid in capital 0.00M 0.00M 0.00M 0.00M
Common stock total equity 0.00M 0.00M 0.00M 0.00M
Preferred stock total equity 0.00M 0.00M 0.00M 0.00M
Retained earnings total equity 0.00M 0.00M 0.00M 0.00M
Treasury stock 0.00M 0.00M 0.00M 0.00M
Accumulated amortization 0.00M 0.00M 0.00M 0.00M
Non currrent assets other 0.00M 0.00M 0.00M 0.00M
Deferred long term asset charges 0.00M 0.00M 0.00M 0.00M
Non current assets total 0.00M 0.00M 0.00M 0.00M
Capital lease obligations 0.00M 0.00M 0.00M 0.00M
Long term debt total 0.00M 0.00M 0.00M 0.00M
Breakdown 2009-12-31 2008-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly
Date 2009-12-31 2008-12-31 2005-12-31 2004-12-31
Investments 0.00M 0.00M 0.00M 0.00M
Change to liabilities 0.00M 0.00M -0.33M -0.01M
Total cashflows from investing activities -1.48M -1.48M -1.48M -1.48M
Net borrowings 0.28M 0.28M 0.39M 0.19M
Total cash from financing activities 1.42M 0.06M 0.49M 0.44M
Change to operating activities 0.00M 0.00M 0.00M 0.00M
Net income -0.15M -0.06M -0.17M -0.41M
Change in cash 0.11M 0.00M -0.01M 0.03M
Total cash from operating activities 0.17M -0.05M -0.51M -0.41M
Depreciation 0.00M 0.00M 0.00M 0.00M
Other cashflows from investing activities 0.00M 0.00M 0.00M 0.00M
Dividends paid 0.00M 0.00M 0.00M 0.00M
Change to inventory 0.32M 0.32M 0.32M 0.32M
Change to account receivables 0.00M 0.00M 0.00M 0.00M
Sale purchase of stock 0.00M 0.00M 0.00M 0.00M
Other cashflows from financing activities 0.46M 0.46M 0.46M -0.20M
Change to netincome 0.00M 0.00M 0.00M 0.00M
Capital expenditures 0.15M 0.15M 0.15M 0.15M
Change receivables 0.00M 0.00M 0.00M 0.00M
Cash flows other operating 0.00M 0.00M 0.00M 0.00M
Exchange rate changes 0.00M 0.00M 0.00M 0.00M
Cash and cash equivalents changes 0.00M 0.00M 0.00M 0.00M

Peer Comparison*

Sector: Real Estate Industry: REIT - Residential

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
NCRRP
NCR Corporation 5.5% PFD CNV A
-
-%
1002.00 857.14 - - -
INVH
Invitation Homes Inc
-0.41
1.49%
26.70 42.22 44.44 8.97 2.05
ESS
Essex Property Trust Inc
-2.40
0.88%
271.06 24.87 46.08 9.04 3.01
MAA
Mid-America Apartment Communities Inc
-
-%
116.25 36.72 33.90 6.67 2.67

Profile*

ChromoCure Inc

ChromoCure, Inc. develops and provides proprietary cancer detection systems. The company offers Chromosomal Scanner Series 200, a cancer detection system to measure the genomic characteristic found in 100% of all cancers and never found in normal cells. It also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research. The company was formerly known as Cyberhand Technologies International, Inc. and changed its name to ChromoCure, Inc. in June 2009. ChromoCure, Inc. was incorporated in 2001 and is based in Reno, Nevada.

5190 Neil Road, Reno, NV, United States, 89502

775-636-6548

4

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…